Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

XRK3F2

🥰Excellent
Catalog No. T13360Cas No. 2375193-43-2

XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.

XRK3F2

XRK3F2

🥰Excellent
Purity: 98.91%
Catalog No. T13360Cas No. 2375193-43-2
XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
Pack SizePriceAvailabilityQuantity
1 mg$34In Stock
5 mg$79In Stock
10 mg$122In Stock
25 mg$236In Stock
50 mg$372In Stock
100 mg$559In Stock
1 mL x 10 mM (in DMSO)$89In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "XRK3F2"

Select Batch
Purity:98.91%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
In vitro
XRK3F2 inhibits p62-ZZ domain signaling and rescues Myeloma-induced Gfi1-driven epigenetic repression of the Runx2 gene in pre-osteoblasts to overcome differentiation suppression. XRK3F2 prevents MM-induced upregulation of Gfi1 and repression of the Runx2 gene when present in MM-preOB co-cultures. p62-ZZ-domain blocking by XRK3F2 prevents MM conditioned media and TNF plus IL7-mediated Gfi1 mRNA upregulation and the concomitant Runx2 repression. XRK3F2 decreased MM-induced GFI1 occupancy at the Runx2-P1 promoter and prevented recruitment of HDAC1, thus preserving the transcriptionally permissive chromatin mark H3K9ac on Runx2 and allowing osteogenic differentiation[1].
Chemical Properties
Molecular Weight435.89
FormulaC23H24ClF2NO3
Cas No.2375193-43-2
SmilesCl.OCCNCc1ccc(OCc2ccc(F)cc2)c(OCc2ccc(F)cc2)c1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 135.0 mg/mL (309.7 mM), Sonication is recommended.
H2O: 0.8 mg/mL (1.9 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM2.2942 mL11.4708 mL22.9416 mL114.7078 mL
DMSO
1mg5mg10mg50mg
5 mM0.4588 mL2.2942 mL4.5883 mL22.9416 mL
10 mM0.2294 mL1.1471 mL2.2942 mL11.4708 mL
20 mM0.1147 mL0.5735 mL1.1471 mL5.7354 mL
50 mM0.0459 mL0.2294 mL0.4588 mL2.2942 mL
100 mM0.0229 mL0.1147 mL0.2294 mL1.1471 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy XRK3F2 | purchase XRK3F2 | XRK3F2 cost | order XRK3F2 | XRK3F2 chemical structure | XRK3F2 in vitro | XRK3F2 formula | XRK3F2 molecular weight